US Stock MarketDetailed Quotes

ACIU AC Immune

Watchlist
  • 2.660
  • -0.070-2.56%
Trading Dec 30 13:15 ET
263.19MMarket Cap-6.00P/E (TTM)
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Trytosaveabit
    Trytosaveabit
    Dec 10 06:03
    Update
    $AC Immune (ACIU.US)$ Reuters· 3 mins ago
    AC Immune SA - ACI-24.060 Safe and Well Tolerated in Down Syndrome Patients
    Trytosaveabit
    Trytosaveabit
    Nov 14 06:03
    Update
    $AC Immune (ACIU.US)$ Reuters· 2 mins ago
    AC Immune Reports Positive Interim Results From Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
    Jaguar8
    Jaguar8
    Nov 14 06:02
    NEWS
    $AC Immune (ACIU.US)$
    AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
    AC Immune (NASDAQ: ACIU) announced positive interim results from its Phase 2 VacSYn trial of ACI-7104.056, an active immunotherapy for early Parkinson's disease.
    The treatment showed significant efficacy, inducing anti-a-synuclein antibody levels 16-fold higherthan placebo after 3 immunizations, with a 100% patient response rate.
    The trial rep...
    amiable Hedgehog_758
    amiable Hedgehog_758
    Sep 17 06:34
    $AC Immune (ACIU.US)$
    AC Immune Reaches Key Milestone in Alzheimer's Immunotherapy, Receives CHF 24.6M
    Benzinga· 10 mins ago5mins
    AC Immune (ACIU.US)
    3.270
    3.530
    +2.83%
    +7.95%
    AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced that it will receive the second ReTain-related milestone payment (CHF 24.6 million) under its agreement with Janssen Pharmaceuticals, Inc. (Janssen), a Johnson & Johnson co...
    Trytosaveabit
    Trytosaveabit
    Sep 17 06:09
    News
    $AC Immune (ACIU.US)$ Press Release: AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease
    Dow Jones· 7 mins ago
    AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease
    AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease
    1
Read more
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+2.24%
Adobe
ADBE
-0.01%
Netflix
NFLX
-0.17%
Taiwan Semiconductor
TSM
-0.16%
Salesforce
CRM
-0.17%

Unlock the Full List